Kevin Herde - 29 Apr 2022 Form 4/A - Amendment Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Chief Financial Officer
Signature
/s/ Kurt Oreshack, by power of attorney for Kevin Herde
Issuer symbol
MRVI
Transactions as of
29 Apr 2022
Net transactions value
+$9,800
Form type
4/A - Amendment
Filing time
27 Jun 2022, 19:55:18 UTC
Date Of Original Report
27 Jun 2022
Previous filing
27 Jan 2022
Next filing
09 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $9,800 +427 +2.1% $22.95 20,816 29 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amended to note that this is a voluntary filing. The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 427 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.